Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04357184 · ClinicalTrials.gov registry record · NA
BFRT for Severe Lower Extremity Muscle Atrophy
A NA study, sponsored by Cincinnati Sportsmedicine Research and Education Foundation.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT04357184 is a NA study that has completed, run by Cincinnati Sportsmedicine Research and Education Foundation. The registered enrollment target is 100 participants.
The verdict
NCT04357184, a NA study, has completed, sponsored by Cincinnati Sportsmedicine Research and Education Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
Muscle weakness or atrophy is a common condition following acute and chronic musculoskeletal injuries. Strength training is an imperative component in clinical rehabilitation of musculoskeletal injuries. Heavy exercise loads (approximately 70% of one repetition maximum) is necessary to elicit muscle hypertrophy and strength gains. However, patients with severe muscle atrophy are frequently unable to tolerate these loads due to pain. Blood flow resistance training with low resistance loads may be used to safely develop muscle strength.
Interventions
- OTHER Blood flow restriction training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2020-04-14 |
| Est. Completion | 2022-02-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04357184
The ClinicalTrials.gov registry entry for NCT04357184 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cincinnati Sportsmedicine Research and Education Foundation, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blood flow restriction training is the first listed.
NCT04357184 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04357184 about?
NCT04357184 is a clinical study titled "BFRT for Severe Lower Extremity Muscle Atrophy". Muscle weakness or atrophy is a common condition following acute and chronic musculoskeletal injuries. Strength training is an imperative component in clinical rehabilitation of musculoskeletal injuries. Heavy exercise loads (approximately 70% of one repetition maximum) is necessary to elicit muscle...
What is the current status of trial NCT04357184?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2020-04-14. Estimated completion is 2022-02-15.
What interventions are being tested in trial NCT04357184?
The interventions under investigation include: Blood flow restriction training (OTHER).
Who is sponsoring clinical trial NCT04357184?
This trial is sponsored by Cincinnati Sportsmedicine Research and Education Foundation, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.